System-generated · Agent desk · Sector Leaders · stock · inception 2026-07-04
Started with ₹10,00,000 · max 10% per position (10 slots).
An agent-run trading desk over Atlas’s ranks (forward-only).
This rulebook was chosen by the system’s walk-forward search, not hand-written — the exact filters above are what won on out-of-sample data. See the Learning log below for how it got here and what it rejected.
Thick bar = this portfolio · thin bar = NIFTY 500 sector weight.
| Instrument | Sector | Qty | Avg cost | Last | Value | Weight | P&L | Comp | Tech | Flow | Val | RS 3M | EMA 50/200 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J&KBANK The Jammu & Kashmir Bank Limited | Banking | 609 | 163.72 | 168.41 | ₹1,02,562 | 10.2% | +2.9% | 95 | 100 | 50 | 61 | +33.4% | ✓/✓ |
| SUNPHARMA Sun Pharmaceutical Industries Limited | Pharma | 52 | 1912.80 | 1938.70 | ₹1,00,812 | 10.1% | +1.4% | 95 | 100 | 50 | 12 | +13.9% | ✓/✓ |
| RBLBANK RBL Bank Limited | Banking | 275 | 362.80 | 362.80 | ₹99,770 | 10.0% | 0.0% | 97 | 100 | 70 | 16 | +9.3% | ✓/✓ |
| ZYDUSLIFE Zydus Lifesciences Limited | Pharma | 86 | 1159.00 | 1159.00 | ₹99,674 | 10.0% | 0.0% | 96 | 100 | 60 | 34 | +23.3% | ✓/✓ |
| KARURVYSYA Karur Vysya Bank Limited | Banking | 328 | 304.15 | 295.65 | ₹96,973 | 9.7% | -2.8% | 92 | 95 | 60 | 20 | +1.7% | ✓/✓ |
| BOSCHLTD Bosch Limited | Automobile | 2 | 41610.00 | 42225.00 | ₹84,450 | 8.4% | +1.5% | 91 | 95 | 52 | 7 | +9.8% | ✓/✓ |
Lessons earned from outcomes (confidence-weighted, weekly reflection)
50% Be selective within banking; mid‑cap banks lacking clear leadership can suffer sharp drops (MAHABANK fell -9.92% in 5 days), so maintain exposure only to clear sector leaders. [basis: MAHABANK, a non‑leader banking stock, experienced a near‑10% decline over 5 days, supporting tighter selection criteria in banking.]
50% Avoid exiting pharma/healthcare positions solely on short‑term momentum weakening; they can still deliver modest upside (NEULANDLAB would have risen +2.92% in 5 days). [basis: NEULANDLAB was exited due to perceived weakening momentum but its 5‑day forward return was positive, indicating premature exits can miss short‑term gains.]
50% In a constructive regime, add only to sectors where the clear leader shows continued relative strength; non‑leader stocks tend to underperform (e.g., KIMS, AJANTPHARM, LAURUSLABS fell 1‑3% in 5 days). [basis: Rejected non‑leader names across banking, pharma and healthcare posted negative 5‑day returns, confirming the need to ride only sector leaders.]
| Date | Instrument | Side | Qty | Price | Value | Cost | Realized P&L | Days | Bucket | Tax | Reason |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | ZYDUSLIFE | buy | 86 | 1159.00 | ₹99,674 | ₹117.62 | — | — | — | — | manual |
| 2026-07-10 | RBLBANK | buy | 275 | 362.80 | ₹99,770 | ₹117.73 | — | — | — | — | manual |
| 2026-07-09 | BOSCHLTD | buy | 2 | 41610.00 | ₹83,220 | ₹98.20 | — | — | — | — | manual |
| 2026-07-09 | NEULANDLAB | sell | 5 | 18889.00 | ₹94,445 | ₹97.28 | ₹-544 | 2 | stcg | ₹0.00 | manual |
| 2026-07-07 | SUNPHARMA | buy | 52 | 1912.80 | ₹99,466 | ₹117.37 | — | — | — | — | manual |
| 2026-07-07 | J&KBANK | buy | 609 | 163.72 | ₹99,705 | ₹117.65 | — | — | — | — | manual |